Galmed Pharmaceuticals
GLMD
$3.04
Share price
-1.69%
Change (1 day)
-52.38%
Change (1 year)
Categories
Galmed Pharmaceuticals (GLMD) - Cash on Hand
Cash on Hand as of September 2024 : NZ$29.98 Million
According to Galmed Pharmaceuticals
's latest financial reports the company has NZ$29.98 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Galmed Pharmaceuticals - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | NZ$19.99 M | -7.93% |
| 2022-12-31 | NZ$21.71 M | -57.4% |
| 2021-12-31 | NZ$50.97 M | -27.73% |
| 2020-12-31 | NZ$70.52 M | -37.08% |
| 2019-12-31 | NZ$0.11 B | -16.63% |
| 2018-12-31 | NZ$0.13 B | 402.66% |
| 2017-12-31 | NZ$26.74 M | 19.94% |
| 2016-12-31 | NZ$22.3 M | -33.64% |
| 2015-12-31 | NZ$33.6 M | -17.68% |
| 2014-12-31 | NZ$40.82 M | 24387.09% |
| 2013-12-31 | NZ$0.16 M | -80.9% |
| 2012-12-31 | NZ$0.87 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | NZ$0.58 B | 1,854.49% | 🇺🇸 USA |
 | NZ$1.36 B | 4,438.62% | 🇮🇪 Ireland |
 | NZ$0.30 B | 906.21% | 🇺🇸 USA |
 | NZ$23.78 M | -20.67% | 🇺🇸 USA |